Prevalence of factor V Leiden, hyperhomocysteinemia, prothrombin G20210A, and methylene tetrahydrofolate reductase C677T mutations in obstetrical complications;Facteur V Leiden, hyperhomocystein mie, mutation C677T de la MTHFR, mutation G20210A de la prothrombine et complications obstetricales

Annales de Biologie Clinique

Volumn 57, Issue 5, 1999, Pages 539-544

  Verdy, E ^a   Berkane, N ^a   Magdelaine, A ^a   Soubrier, F ^a   Uzan, S ^a  

^a HÔPITAL TENON   (France)

Author keywords

Genetic; Obstetrical complications; Thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENINE; BLOOD CLOTTING FACTOR 5; GUANINE; NUCLEOTIDE; PROTHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASE;

ARTICLE; CIRCULATION; DISEASE PREDISPOSITION; FEMALE; FETUS DEATH; GENE MUTATION; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; INFARCTION; INTRAUTERINE GROWTH RETARDATION; MOTHER FETUS RELATIONSHIP; OBSTETRICS; PATHOGENESIS; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY; PREVALENCE; RISK FACTOR; THERAPY; THROMBOSIS; BLOOD; ENZYMOLOGY; FETUS; GENETIC PREDISPOSITION; GENETICS; MUTATION; PLACENTA; POINT MUTATION; PREGNANCY COMPLICATION; REVIEW; VASCULARIZATION;

FACTOR V; FEMALE; FETAL DEATH; FETAL GROWTH RETARDATION; FETUS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERHOMOCYSTEINEMIA; INFARCTION; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PLACENTA; POINT MUTATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PROTHROMBIN; THROMBOSIS;

EID: 0032881843     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Conard J, Horellou MH, Van Dreden P, Lecompte T, Samama M. Thrombosis and pregnancy in congenital deficiencies in ATIII, protein C or protein S : study of 78 women. Thromb Haemost 1990 ; 63 : 319-20.
2. Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996 ; 348 : 913-6.
3. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously inrecognized mechanism characterized by poor anticoagulant response to activated protein C : prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993 ; 90 : 1004-8.
4. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994 ; 369 : 64-7.
5. Magdelaine A, Soubrier F, Berkane N, Uzan S, Verdy E. Comparaison de trois réactifs pour la détection de la résistance à la protéine C activée lié à la mutation du facteur V Leiden en cours de grossesse. Ann Biol Clin 1998 ; 56 : 445-50.
6. Tripodi A, Negri B, Bertina RM, Mannucci PR. Screening for the FV : Q506 mutation. Evaluation of thirteen plasma-based methods for their diagnosis efficacity in comparison with DNA analysis. Thromb Haemost 1997 ; 77 : 436-9.
7. Williamson D, Brown K, Luddington R, Baglin C, Baglin T. Factor V Cambridge : a new mutation (Arg 306 Thr) associated with resistance to activated protein C. Blood 1998 ; 91 : 1140-4.
8. Zittoun J. Homocystéine et pathologie vasculaire. Hématologie 1998 ; 4 : 7-16.
9. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease : a common mutation in methylene tetrahydrofolate reductase. Nature Genet 1995 ; 10 : 111-3.
10. Chango A, Parrot-Roulaud F, Nicolas JP. Génétique moléculaire de la reméthylation de l'homocystéine. Ann Biol Clin 1999 ; 57 : 37-42.
11. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996 ; 88 : 3698-703.
12. Bokarewa MI, Bremme K, Blombäck M. Arg506G mutation in factor V and risk of thrombosis during pregnancy. Br J Haematol 1996 ; 92 : 473-8.
13. Dizon-Townson DS, Nelson LM, Jang H, Varner MW, Ward K. The incidence of the factor V Leiden mutation in an obstetric population and its relation to deep vein thrombosis. Am J Obstet Gynecol 1997 ; 176 : 883-6.
14. Dizon-Townson DS, Nelson LM, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996 ; 175 : 902-5.
15. Lindoff C, Ingemarsson I, Martinsson G, Segelmark M, Thysell H, Astedt B. Preeclampsia is associated with a reduced response to activated protein C. Am J Obstet Gynecol 1997 ; 176 : 457-60.
16. Grandone E, Margaglione M, Colaizzo D, et al. Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997 ; 77 : 1052-4.
17. Ray R, Regan L, Hadley E, Dave M, Cohen H. Second-trimester pregnancy loss is associated with activated protein C resistance. Br J Haematol 1996 ; 92 : 489-90.
18. Grandone E, Margaglione M, Colaizzo D, et al. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997 ; 77 : 822-4.
19. Grandone E, Margaglione M, Colaizzo D, et al. Genetic susceptibility to pregnancy-related venous thromboembolism : roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol 1998 ; 179 : 1324-8.
20. Dekker GA, de Vries JIP, Doelitzsch PM, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995 ; 173 : 1042-8.
21. Leeda M, Riyazi N, de Vries JIP, Jakobs C, van Geijn HP, Dekker GA. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. Am J Obstet Gynecol 1998 ; 179 : 135-9.
22. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997 ; 34 : 525-6.
23. Wouters MG, Boers GH, Blom HJ, et al. Hyperhomocysteinemia : a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993 ; 60 : 820-5.
24. Coumans ABC, Huijgens PC, Jakobs C, et al. Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion. Human Reproduction 1999 ; 14 : 211-4.
25. Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999 ; 340 : 9-13.
26. Sibai BM. Thrombophilias and adverse outcomes of pregnancy. What should a clinician do ? New Engl J Med 1999 ; 340 : 50-2.